Satoshi Itano

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

PK Judge, Natalie Staplin, KJ Mayne et al. · The Lancet Diabetes & Endocrinology · 2023 · 88 citations · Full text

A simultaneous monitoring of Lens culinaris agglutinin A-reactive alpha-fetoprotein and des-gamma-carboxy prothrombin as an early diagnosis of hepatocellular carcinoma in the follow-up of cirrhotic patients.

Yoshihiro Shimauchi, Masatoshi Tanaka, Ryoko Kuromatsu et al. · Oncology Reports · 2000 · 66 citations

Initial Experience of Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma in Real-World Clinical Practice

Hideki Iwamoto, Shigeo Shimose, Yu Noda et al. · Cancers · 2021 · 58 citations · Full text

Prophylactic Lamivudine Administration Prevents Exacerbation of Liver Damage in HBe Antigen Positive Patients with Hepatocellular Carcinoma Undergoing Transhepatic Arterial Infusion Chemotherapy

Hiroaki Nagamatsu, Satoshi Itano, Sakae Nagaoka et al. · The American Journal of Gastroenterology · 2004 · 54 citations

Value of fusing PET plus CT images in hepatocellular carcinoma and combined hepatocellular and cholangiocarcinoma patients with extrahepatic metastases: preliminary findings

Sakae Nagaoka, Satoshi Itano, Masatoshi Ishibashi et al. · Liver International · 2006 · 45 citations